Experimental Design Details
This study uses a randomized, within-subject discrete choice experiment (DCE) to investigate public preferences for alternative policy responses to a hypothetical future hantavirus epidemic. The experiment is embedded within a single-session online survey administered to adult respondents recruited from Italy and the United States through the Qualtrics survey platform. Country-specific quota sampling is used to obtain samples that broadly reflect the demographic composition of the adult populations.
After providing informed consent, respondents complete a structured questionnaire collecting information on sociodemographic characteristics, health status, COVID-19 experiences, COVID-19 vaccination history, attitudes toward vaccines, trust in institutions and information sources, political orientation, and risk literacy. Participants are then introduced to a standardized hypothetical hantavirus outbreak scenario and instructed that they will evaluate alternative public health response strategies.
Each respondent completes eight discrete choice tasks. In every task, participants choose their preferred option among three alternatives:
Vaccination strategy
Restriction-based strategy
No new public health measures
The vaccination alternative is defined by four experimentally manipulated attributes: vaccine efficacy (60% or 90%), probability of serious side effects (1 in 10,000; 1 in 100,000; or 1 in 1,000,000), regulatory approval status (accelerated review, emergency authorization, or full approval), and recommending authority (national health authority or international health organization).
The restriction alternative varies according to restriction type (mandatory masking, workplace and school closures, local lockdowns, quarantine of close contacts, or related combinations), restriction duration (1, 3, or 6 months), and the associated economic and social burden (none, low, moderate, or high).
The no-new-measures alternative remains constant across all tasks and represents continuation of voluntary recommendations without additional vaccination campaigns, mandates, or restrictions.
For every alternative in each choice task, projected hospitalizations and projected deaths per 100,000 population over the following six months are presented. These health outcome levels vary systematically across alternatives and choice tasks as part of the experimental design.
The combinations of attribute levels are generated using an efficient fractional factorial design that minimizes correlation among attributes while maximizing statistical efficiency for estimating marginal utilities. Implausible or dominant profiles are avoided during the experimental design process. The order of the eight choice tasks is randomized independently for each respondent to reduce potential order, learning, and fatigue effects.
The unit of analysis is the respondent-choice task observation, with each participant contributing up to eight observations. The primary outcome is the selected alternative in each choice task. Preference parameters are estimated using mixed logit (random-parameters logit) models that account for repeated choices within respondents and allow for individual-level preference heterogeneity. Conditional logit models are estimated as robustness checks, while latent class logit models are used as exploratory analyses to identify discrete preference segments.
Pre-specified interaction analyses examine whether preferences vary according to respondents' trust in public institutions, previous COVID-19 experiences, vaccine attitudes, political orientation, risk literacy, chronic illness status, and prior vaccination history. Additional analyses compare preference structures between the Italian and U.S. samples and estimate respondents' willingness to trade off health outcomes against the duration and burden of public health restrictions. Respondents who fail predefined eligibility or data-quality criteria, including incomplete surveys, attention-check failures, duplicate participation, or implausibly short completion times, are excluded from the primary analyses in accordance with the preregistered analysis plan.